What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Cancer
Munir Pirmohamed mainly focuses on Pharmacology, Immunology, Pharmacogenetics, Drug and Metabolite.
His studies in Pharmacology integrate themes in fields like P-glycoprotein, Toxicity and In vivo.
His Immunology study deals with Genotype intersecting with Bioinformatics.
He has included themes like Guideline, Internal medicine, Warfarin and Intensive care medicine in his Pharmacogenetics study.
The study incorporates disciplines such as Gastroenterology and Phenytoin in addition to Internal medicine.
The Drug study combines topics in areas such as Idiosyncrasy and Hapten.
His most cited work include:
- Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients (2276 citations)
- Phase I Clinical Trial of Oral Curcumin: Biomarkers of Systemic Activity and Compliance (920 citations)
- Drug repurposing: progress, challenges and recommendations (802 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Pharmacology, Internal medicine, Immunology, Pharmacogenetics and Drug.
His work carried out in the field of Pharmacology brings together such families of science as Metabolite, Carbamazepine, Toxicity and In vivo.
Munir Pirmohamed interconnects Gastroenterology and Endocrinology in the investigation of issues within Internal medicine.
Munir Pirmohamed has included themes like Genome-wide association study and Allele in his Immunology study.
His research in Pharmacogenetics intersects with topics in Abacavir, Bioinformatics, Warfarin and Intensive care medicine.
His work deals with themes such as Pharmacogenomics, Disease, Dosing and Drug reaction, which intersect with Intensive care medicine.
He most often published in these fields:
- Pharmacology (23.14%)
- Internal medicine (21.56%)
- Immunology (17.17%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (21.56%)
- Pharmacogenomics (9.50%)
- Intensive care medicine (14.01%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Pharmacogenomics, Intensive care medicine, Immunology and Pharmacology.
The Internal medicine study combines topics in areas such as Gastroenterology, Genome-wide association study and Oncology.
In his study, Randomized controlled trial is strongly linked to Clinical trial, which falls under the umbrella field of Pharmacogenomics.
His Intensive care medicine research includes themes of Disease, MEDLINE, Warfarin and Nephrotoxicity.
Pharmacology connects with themes related to Pharmacogenetics in his study.
His biological study spans a wide range of topics, including Carbamazepine, Dosing and Abacavir.
Between 2016 and 2021, his most popular works were:
- Drug repurposing: progress, challenges and recommendations (802 citations)
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update. (230 citations)
- Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium (131 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Cancer
Munir Pirmohamed mainly investigates Internal medicine, Pharmacogenomics, Pharmacology, Pharmacogenetics and Intensive care medicine.
The study incorporates disciplines such as Physical therapy and Single-nucleotide polymorphism in addition to Internal medicine.
He combines subjects such as Precision medicine, Clinical trial, Personalized medicine and Disease with his study of Pharmacogenomics.
His Pharmacology research is mostly focused on the topic Drug reaction.
His work carried out in the field of Pharmacogenetics brings together such families of science as Guideline, Gout, Asthma and Allopurinol.
His Intensive care medicine study combines topics from a wide range of disciplines, such as Nephrology, Warfarin, Nephrotoxicity, Young adult and Drug.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
